Bruker BioSciences Corporation to Release Fourth Quarter and Full Year 2007 Financial Results on February 28, 2008
21 February 2008 - 11:15PM
Business Wire
Bruker BioSciences Corporation (NASDAQ:BRKR) announced today that
it plans to release its fourth quarter and full year 2007 financial
results on Thursday, February 28, 2008 before the market opens.
Bruker BioSciences will then host an operator-assisted earnings
conference call that morning at 9 a.m. Eastern Time. To listen to
the webcast, investors can go to www.bruker-biosciences.com and
click on the live web broadcast symbol. The webcast will be
available through the Company web site for 30 days. Investors can
also listen and participate on the telephone in the US and Canada
by calling 888-339-2688, or 617-847-3007 outside the US and Canada.
Investors should refer to the Bruker BioSciences Earnings Call. A
telephone replay of the conference call will be available one hour
after the conference call by dialing 888-286-8010 in the US and
Canada, or 617-801-6888 outside the US and Canada, and then
entering replay pass code 11927586. ABOUT BRUKER BIOSCIENCES
(NASDAQ:BRKR) Bruker BioSciences Corporation, headquartered in
Billerica, Massachusetts, is the publicly traded parent company of
Bruker AXS Inc., Bruker Daltonics Inc. and Bruker Optics Inc. The
Company is a leading developer and provider of advanced X-ray tools
used primarily in life science and materials research, as well as
of X-ray and OES elemental analysis instrumentation used primarily
in industrial applications. It is also a leading developer and
provider of innovative life science tools based on mass
spectrometry and develops and provides a broad range of field
analytical systems for chemical, biological, radiological and
nuclear detection. In addition, it is a leading developer and
provider of research, analytical and process analysis instruments
and solutions based on infrared and Raman molecular spectroscopy
technology. For more information, please visit
www.bruker-biosciences.com. CAUTIONARY STATEMENT OF BRUKER
BIOSCIENCES Any statements contained in this press release that do
not describe historical facts may constitute forward-looking
statements as that term is defined in the Private Securities
Litigation Reform Act of 1995. Any forward-looking statements
contained herein are based on current expectations, but are subject
to a number of risks and uncertainties. The factors that could
cause actual future results to differ materially from current
expectations include, but are not limited to, risks and
uncertainties relating to the integration of businesses we have
acquired or may acquire in the future, changing technologies,
product development and market acceptance of our products, the cost
and pricing of our products, manufacturing, competition, dependence
on collaborative partners and key suppliers, capital spending and
government funding policies, changes in governmental regulations,
intellectual property rights, litigation, and exposure to foreign
currency fluctuations. These and other factors are identified and
described in more detail in our filings with the SEC, including,
without limitation, our annual report on Form 10-K for the year
ended Dec. 31, 2006, our most recent quarterly reports on Form 10-Q
and our current reports on Form 8-K. We disclaim any intent or
obligation to update these forward-looking statements other than as
required by law.
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jul 2023 to Jul 2024